Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Title:

Abbravation: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers-Plenum Publishers

Search In Publisher:

DOI

10.1002/ijc.28159

Search In DOI:

ISSN

0090-466X

Search In ISSN:
Search In Title Of Papers:

Pharmacodynamic modeling of theEmphasis Type="Ita

Authors: TsangBin Tzeng HoLeung Fung
Publish Date: 1992/06/01
Volume: 20, Issue: 3, Pages: 227-251
PDF Link

Abstract

The in vitrodoserelaxation curves of four isomeric organic mononitrates Lisoidide mononitrate LIIMN isosorbide2mononitrate IS2MN isomannide mononitrate IMMN and isosorbide5mononitrate IS5MN were determined with rat aorta rings These mononitrates relaxed vascular tissue in a concentrationdependent manner Based upon the EC50obtained from the Hill equation the relative potency of LIIMN IS2MN IMMN IS5MN was 432122231 The Hill exponential coefficients were identical value of about 15 in these four isomeric mononitrates suggesting that they are likely to have a common mechanism of action For all four isomers relaxation was fairly immediate after addition of the tested compound into the tissue bath with a 2 to 3 mindelay to reach steadystate effect The rates of relaxation were then used to construct a pharmacodynamic model that described the time course of relaxation for these compounds This theoretical analysis suggested that in vitronitrate action is mediated by a catenary process consistent with published biochemical evidence that suggests a series of reactions involving metabolic activation to nitric oxide production of cyclic GMP and myosin lightchain phosphorylation to produce relaxation Via this pharmacodynamic model the halflives of nitric oxide and cGMP in the smooth muscle cells were estimated to be 152 and 231 sec respectively consistent with literature reports Results from the present study indicated the potential use of in vitropharmacodynamic modeling in confirming mechanisms of drug action obtained through biochemical or other methods


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and a “well-stirred” model
  2. Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies
  3. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma
  4. A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients
  5. Linear pharmacokinetic models: Geometric construction to determine transfer and elimination rate constants
  6. Modeling of drug response in individual subjects
  7. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model
  8. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man
  9. Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans
  10. Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: Effect of model misspecification
  11. Estimation of drug binding parameters
  12. Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing
  13. Pharmacokinetics of teicoplanin in man after intravenous administration
  14. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics
  15. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  16. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  17. Simulation for population analysis of Michaelis-Menten elimination kinetics

Search Result: